8-K ·Filed Sep 16, 2026
8-K context-dependent: Items 5.02
Actionable Insight • Neutral
Routine board appointment — no immediate trading catalyst. Monitor future filings for any strategic shifts or pipeline updates.
Latest settled — T+20d ⚠ clustered
ERNA ▼ -42.29% at T+20d
NEUTRAL call -42.29% · α vs SPY -43.49% · entry $3.76 → $2.17
Latest observation: T+26 -30.47% FF3 residual α
T+1d
+1.86%
call +1.86% · α +1.98%
$3.83
settled 6w ago
T+5d
-3.72%
call -3.72% · α -4.32%
$3.62
settled 5w ago
T+20d
-42.29%
call -42.29% · α -43.49%
$2.17
settled 13d ago
T+60d
Pending
in 6w
Price Chart
Loading chart...
Executive Summary
Ernexa Therapeutics appointed Robert J. Spiegel, M.D. to its board of directors, effective immediately. This is a routine board appointment with no material financial impact or strategic change. The filing contains no financial data or guidance.
Key Facts
- Robert J. Spiegel, M.D. appointed to the Board of Directors effective September 14, 2026.
- Dr. Spiegel will be compensated under the Board of Directors Compensation Plan adopted August 15, 2026.
- No arrangements, family relationships, or reportable transactions exist between Dr. Spiegel and the company.
Financial Impact
No financial impact disclosed.
Risk Factors
- No material risks identified from this filing.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-042934 |
| Document: 0001493152-26-042934-index-headers.html | 0001493152-26-042934 |
| Document: 0001493152-26-042934-index.html | 0001493152-26-042934 |
| Document: 0001493152-26-042934.txt | 0001493152-26-042934 |
13 reports for ERNA
33% Hit rate @ T+5 Went positive at some point 2 of 3 best @ T+20▲ +96.38%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | Press Release | $2.08 | awaiting T+5 | — | $1.94 (−6.51%) |
Oct 15, 2026 11d ago | 8-K | $2.09 $2.07 | ▼ −1.20% | ▼ −0.77% | $1.94 (−7.18%) |
Oct 1, 2026 25d ago | Press Release | $2.96 $2.49 | ▼ −15.88% | ▼ −17.18% | $1.94 (−34.46%) |
Sep 30, 2026 26d ago | Press Release | $3.20 $2.39 | ▼ −25.31% | ▼ −27.23% | $1.94 (−39.37%) |
Sep 16, 2026 5w ago | 8-K | $3.76 $3.62 | ▼ −3.72% | ▼ −4.32% | $1.94 (−48.40%) |
Sep 16, 2026 5w ago | 8-K | $3.76 $3.62 | ▼ −3.72% | ▼ −4.32% | $1.94 (−48.40%) |
Jul 14, 2026 14w ago | Press Release | $6.06 $5.43 | ▼ −10.40% | ▼ −9.10% | $1.94 (−67.99%) |
Jun 26, 2026 17w ago | 8-K | $7.03 $6.44 | ▼ −8.39% | ▼ −9.78% | $1.94 (−72.40%) |
Jun 17, 2026 18w ago | Press Release | $5.89 $6.30 | ▲ +6.96% | ▲ +8.00% | $1.94 (−67.06%) |
May 27, 2026 21w ago | Press Release | $11.14 $8.00 | ▼ −28.19% | ▼ −29.39% | $1.94 (−82.59%) |
Showing 10 of 13
US Market Status
Market Closed — Opens in 1h 1m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers